Are cancer patients better off if they participate in clinical trials? A mixed methods study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Are cancer patients better off if they participate in clinical trials? A mixed methods study
Authors
Keywords
-
Journal
BMC CANCER
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-08
DOI
10.1186/s12885-020-06916-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer patients’ perceptions of factors influencing their decisions on participation in clinical drug trials: A qualitative meta-synthesis
- (2019) Zandra Engelbak Nielsen et al. JOURNAL OF CLINICAL NURSING
- Publication bias examined in meta-analyses from psychology and medicine: A meta-meta-analysis
- (2019) Robbie C. M. van Aert et al. PLoS One
- Randomised controlled trials - the gold standard for effectiveness research
- (2018) Eduardo Hariton et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results
- (2018) Sabino De Placido et al. BREAST
- When Nursing Care and Clinical Trials Coincide: A Qualitative Study of the Views of Nordic Oncology and Hematology Nurses on Ethical Work Challenges
- (2018) Tove E. Godskesen et al. Journal of Empirical Research on Human Research Ethics
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Self-reported quality of life and hope in phase-I trial participants: An observational prospective cohort study
- (2018) Diane A. van der Biessen et al. EUROPEAN JOURNAL OF CANCER CARE
- Patients’ reasoning regarding the decision to participate in clinical cancer trials: an interview study
- (2018) Pia Dellson et al. Trials
- Quality of online information about phase I clinical cancer trials in Sweden, Denmark and Norway
- (2018) Tove E. Godskesen et al. EUROPEAN JOURNAL OF CANCER CARE
- More than one-third of systematic reviews did not fully report the adverse events outcome
- (2018) Rachael Parsons et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care
- (2017) Chloe Goldman et al. ONCOLOGY
- Bevacizumab for Ovarian Cancer at High Risk of Progression: Reproducibility of Trial Results in ‘Real-world’ Patients
- (2016) GIANFILIPPO BERTELLI et al. ANTICANCER RESEARCH
- Impact of clinical trial on survival outcomes
- (2016) Fanny Le Du et al. BREAST CANCER RESEARCH AND TREATMENT
- Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials
- (2016) Oscar Arrieta et al. ONCOLOGY
- Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey
- (2016) Sing Yu Moorcraft et al. Trials
- Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review
- (2016) Su Golder et al. PLOS MEDICINE
- Value of treatment in clinical trials versus the real world: the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden
- (2016) Johanna Svensson et al. Scandinavian Journal of Urology
- The Use of Superlatives in Cancer Research
- (2016) Matthew V. Abola et al. JAMA Oncology
- Always look at the bright side of drugs?
- (2015) Peter Nygren ACTA ONCOLOGICA
- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
- (2015) N. I. Cherny et al. ANNALS OF ONCOLOGY
- Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial
- (2015) Nandita Khera et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Qualitative and mixed methods research in trials
- (2015) Claire Snowdon Trials
- Standards for Reporting Qualitative Research
- (2014) Bridget C. O’Brien et al. ACADEMIC MEDICINE
- Dissemination and publication of research findings: an updated review of related biases
- (2014) F Song et al. HEALTH TECHNOLOGY ASSESSMENT
- Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials*
- (2013) A. J. Templeton et al. ANNALS OF ONCOLOGY
- Clinical trial participation and outcome for patients with glioblastoma: Multivariate analysis from a comprehensive dataset
- (2013) Kathryn M. Field et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation
- (2013) Tove Godskesen et al. SUPPORTIVE CARE IN CANCER
- Research Participants' High Expectations of Benefit in Early-Phase Oncology Trials: Are We Asking the Right Question?
- (2012) Kevin P. Weinfurt et al. JOURNAL OF CLINICAL ONCOLOGY
- Reasons given by patients for participating, or not, in Phase 1 cancer trials
- (2011) S. Catt et al. EUROPEAN JOURNAL OF CANCER
- Progress in Cancer Care: The Hope, the Hype, and the Gap Between Reality and Perception
- (2008) Leonard B. Saltz JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started